. At the time of bronchial challenge, patients had to have withdrawn their regular treatment as per EAACI guidelines [4] . Data were analyzed using SAS v9.3 (SAS, Institute). The groups were compared using the  2 test. Nonnormally distributed variables were compared using the Mann-Whitney test and multiple comparisons using the Bonferroni test. A P value ≤.05 was considered significant.
Seventy-five patients (56% women) were included. Fortythree (57%) had moderate persistent asthma, and 32 (43%) had severe asthma. The clinical characteristics are listed in the Table. Twenty-four patients had a positive bronchial challenge result (32%): 17 with an early asthmatic response, 1 with a prolonged early response, 4 with a dual response, and 2 with a late isolated response. Fifty-one patients had a negative result (68%). Seventy-two FeNOpre and 66 FeNOpost measurements were performed. A significant increase in FeNO levels (9 ppb [3] ) after bronchial challenge was found in patients with a positive result with L-ASA (P=.004), whereas no significant increase in FeNOpost (1.7 ppb [2] ) was observed in the negative bronchial challenge group (P=.409). Regardless of baseline FeNO (FeNOpre <40 ppb and ≥40 ppb), patients with a positive bronchial challenge result experienced a significant increase in FeNO after bronchial challenge with L-ASA (P<.001). This was not the case when the result of the challenge test was negative (P=.527). The median (IQR) peripheral eosinophil count was 245/mm 3 (30-3440) in positive bronchial challenge and 260/mm 3 (0-1440) in negative bronchial challenge. This difference was not statistically significant. No significant differences were found for the other variables analyzed (Table) .
AIA was confirmed by bronchial challenge with L-ASA in 32% of patients with a suspected clinical history of reaction to NSAIDs. This finding is in line with previous publications by our group [2] . A significant increase in FeNO levels after the L-ASA inhalation test was observed only in AIA confirmed by a positive bronchial challenge (P=.004). Increases in FeNO levels after bronchial challenge with specific allergens have been reported [3] . In contrast, Jerschow et al [5] reported a decrease in FeNO levels after oral challenge with 40 mg of aspirin. We speculate that this difference could be due to the type of challenge (oral vs bronchial) and/or the timing of measurement of FeNO levels (24 hours after challenge vs during the first hour after administration of aspirin) [5] . Moreover, the patients in the studies reported did not present a decrease in FEV 1 ≥20% after oral aspirin, whereas all of the challengepositive patients experienced a drop in FEV 1 ≥20% [5] . The only study to investigate AIA and changes in NO levels after challenge with L-ASA was performed in 2009 by Rolla et al [6] , who determined whether inhalation of L-ASA could affect FeNO levels in patients with previously confirmed AERD. The study included only 20 mild asthmatic patients and 10 nonasthmatic patients as a control group, in contrast with the 75 asthmatic patients (43 with moderate persistent asthma and 32 with severe asthma) included in the present study. Similarly, Rolla et al obtained a significant increase in FeNOpost only in the challenge-positive group (P<.001). FeNOpre levels were similar in both studies (29.5 ppb). The increase in FeNOpost levels we observed (9 ppb) was lower than that reported by Rolla et al and can be explained by the heterogeneous clinical characteristics of patients included in both studies. For example, 89% of the patients were diagnosed with CRS and/or nasal polyposis compared with the 33.3% prevalence of rhinitis. The authors reported a significant correlation between the increase in sputum eosinophils and the increase in FeNO in AIA patients after inhalation of L-ASA as an indicator of a type 2 inflammatory phenotype [6] . In recent decades, IL-13 has proven to be an inflammatory cytokine involved in the type 2 pathway, particularly as a key regulator in NO production and in recruitment of eosinophils in the airway [7] [8] [9] . Based on these findings, the inflammatory mechanism may explain the increase in FeNO level in AIA patients after bronchial challenge with L-ASA. Similarly, it can be hypothesized that cytokines such as IL-5, IL-4, IL-13, and even IgE play a vital role in the pathogenesis of AERD, enabling AIA patients to benefit from therapy with biologics [7] [8] [9] [10] .
To the best of our knowledge, we report the first large sample of patients with severe and moderate asthma in whom changes in FeNO levels after bronchial challenge with L-ASA have been evaluated.
Salmon roe, which is also known as salmon caviar, red caviar, or ikura and is frequently consumed in countries such as Japan or Russia, is a delicacy commonly served in sushibased meals [1, 2] . Allergic reactions to salmon roe have been reported in Japan [3, 4] , and a few cases were recently described in western countries (3 cases in France [5] , 2 cases in the USA [2, 6] ). Nevertheless, studies on the allergenicity of salmon roe are rare [7] .
We report the first case of salmon roe anaphylaxis in a young adult in Portugal. A 26-year-old man with a history of mild controlled persistent asthma and persistent, moderatesevere allergic rhinitis who was sensitized to house dust mites was admitted to our emergency department complaining of dyspnea, rhinorrhea, ocular pruritus, epigastric pain, and nausea. The symptoms began a few minutes after the ingestion of a sushi meal comprising rice, salmon, salmon roe, wasabi, soy, and ginger and were treated with intramuscular epinephrine, intravenous corticosteroids, and antihistamines. Uvular edema persisted in the emergency department. The patient denied having eaten other foods, taken any drugs (including nonsteroidal anti-inflammatory drugs), being infected, or having recently exercised. Skin prick tests with commercial food extracts were negative for salmon and other fish, shellfish, soy, rice, total egg, egg white, egg yolk, ovalbumin, and ovomucoid. Skin prick-prick tests were positive for chum salmon (Oncorhynchus keta) roe (17×10 mm) and negative for egg (white and yolk), ginger, salmon, flying fish roe (tobiko), sturgeon roe (caviar), and black scabbard fish roe. Specific IgE (sIgE) was 0.28 kU A /L
